6877 Stock Overview
CLSA Premium Limited, an investment holding company, sells healthcare products in Australia and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
CLSA Premium Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.07 |
| 52 Week High | HK$0.23 |
| 52 Week Low | HK$0.051 |
| Beta | 1.74 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -36.36% |
| 3 Year Change | -64.29% |
| 5 Year Change | -84.27% |
| Change since IPO | -84.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6877 | HK Capital Markets | HK Market | |
|---|---|---|---|
| 7D | 0% | -4.1% | -2.0% |
| 1Y | -36.4% | -33.6% | -14.3% |
Return vs Industry: 6877 underperformed the Hong Kong Capital Markets industry which returned -17.5% over the past year.
Return vs Market: 6877 underperformed the Hong Kong Market which returned -13.7% over the past year.
Price Volatility
| 6877 volatility | |
|---|---|
| 6877 Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 7.5% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in HK Market | 14.9% |
| 10% least volatile stocks in HK Market | 3.8% |
Stable Share Price: 6877 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 6877's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 8 | n/a | www.clsapremium.com |
CLSA Premium Limited, an investment holding company, sells healthcare products in Australia and Hong Kong. The company operates through Healthcare Products and Margin Dealing segments. It also offers leveraged foreign exchange trading, commodity and index trading, leveraged bullion, and other trading services.
CLSA Premium Limited Fundamentals Summary
| 6877 fundamental statistics | |
|---|---|
| Market cap | HK$142.33m |
| Earnings (TTM) | -HK$29.52m |
| Revenue (TTM) | HK$40.87m |
3.5x
P/S Ratio-4.8x
P/E RatioIs 6877 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6877 income statement (TTM) | |
|---|---|
| Revenue | HK$40.87m |
| Cost of Revenue | HK$37.18m |
| Gross Profit | HK$3.70m |
| Other Expenses | HK$33.21m |
| Earnings | -HK$29.52m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.015 |
| Gross Margin | 9.04% |
| Net Profit Margin | -72.22% |
| Debt/Equity Ratio | 0.005% |
How did 6877 perform over the long term?
See historical performance and comparison